| Home > In process > Motivation, Worries and Digital Affinity in Cognitive Screening - Qualitative Findings From the CogScreen Study. |
| Journal Article | DZNE-2026-01204 |
; ; ; ; ; ; ; ;
2027
Sage
London
This record in other databases:
Please use a persistent id in citations: doi:10.1177/08919887261429558
Abstract: Background: Subjective cognitive decline is considered one of the earliest signs of Alzheimer's disease (AD), making early detection crucial for disease-modifying treatments to have the greatest impact. The CogScreen study, supported by the Davos Alzheimer's Collaborative Healthcare System Preparedness Program, evaluates tools for community-based screening of AD in its early stages. This study investigates subjective experiences, focusing on motivations, concerns, and potential improvements regarding digital tools used in cognitive assessments.Methods: Semi-structured qualitative interviews were conducted with a random selection of 28 participants with subjective cognitive decline or healthy controls. Interviews were transcribed and analyzed using conventional content analysis (MAXQDA, VERBI Software, 2024). Results: Analysis identified emergent themes related to the usability of digital tools, the importance of clear communication, and the desire for a more personalized research experience. Participants highlighted motivations and concerns regarding the implementation of digital assessments. Discussion: Findings support the feasibility of integrating digital assessments in aging populations and underscore the importance of addressing participants' motivations, concerns, and digital affinity when introducing innovative tools into clinical practice. Conclusion: Insights from this study contribute to future participant engagement strategies and the development of early detection methods for cognitive impairment. Trial Registration: CogScreen is registered at ClinicalTrials.gov (NCT06191952).
Keyword(s): Aged (MeSH) ; Aged, 80 and over (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Alzheimer Disease: diagnosis (MeSH) ; Alzheimer Disease: psychology (MeSH) ; Cognitive Dysfunction: diagnosis (MeSH) ; Cognitive Dysfunction: psychology (MeSH) ; Digital Health (MeSH) ; Digital Media (MeSH) ; Early Diagnosis (MeSH) ; Mass Screening (MeSH) ; Motivation (MeSH) ; Qualitative Research (MeSH) ; Randomized Controlled Trials as Topic (MeSH) ; Alzheimer disease/diagnostic imaging ; attitudes ; dementia ; early medical intervention ; health knowledge ; healthcare preparedness for Alzheimer’s disease early diagnosis ; mild cognitive impairment ; patient empowerment and shared decision making ; patient reaction to diagnostic disclosure ; practice
|
The record appears in these collections: |